Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3948153rdf:typepubmed:Citationlld:pubmed
pubmed-article:3948153lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:3948153lifeskim:mentionsumls-concept:C0005528lld:lifeskim
pubmed-article:3948153lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:3948153lifeskim:mentionsumls-concept:C0178638lld:lifeskim
pubmed-article:3948153lifeskim:mentionsumls-concept:C0049315lld:lifeskim
pubmed-article:3948153lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3948153lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:3948153pubmed:issue4 Pt 1lld:pubmed
pubmed-article:3948153pubmed:dateCreated1986-4-23lld:pubmed
pubmed-article:3948153pubmed:abstractTextFolate is transported into L1210 mouse leukemia cells by the same system that mediates the uptake of methotrexate and reduced folate compounds. This conclusion is supported by the following observations: (a) methotrexate competitively inhibits the influx of folate and the Ki is comparable to the Kt for methotrexate influx; (b) the profile for inhibition of folate influx by methotrexate is monophasic and complete inhibition is achieved at high concentrations of the competitor; (c) folate inhibits the influx of methotrexate and the Ki is comparable to the Kt for folate influx; (d) the N-hydroxysuccinimide ester of methotrexate, a potent and specific irreversible inhibitor of the reduced folate system, also blocks the influx of folate; (e) folate and methotrexate influx are both inhibited by low concentrations of p-chloromercuriphenylsulfonate; and (f) folate influx fluctuates with the anionic composition of the medium in the same fashion as the influx of methotrexate. Measurements of folate influx can be complicated by the fact that the 3H-labeled substrate is susceptible to decomposition and that labeled breakdown products at concentrations as low as 1% contribute appreciably to the observed uptake. Of these products, 6-hydroxymethylpterin appears to account for most of the extraneous uptake. Impurities can be eliminated by subjecting the [3H]folate to preparative thin-layer chromatography immediately prior to use.lld:pubmed
pubmed-article:3948153pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:languageenglld:pubmed
pubmed-article:3948153pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:citationSubsetIMlld:pubmed
pubmed-article:3948153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3948153pubmed:statusMEDLINElld:pubmed
pubmed-article:3948153pubmed:monthAprlld:pubmed
pubmed-article:3948153pubmed:issn0008-5472lld:pubmed
pubmed-article:3948153pubmed:authorpubmed-author:HuennekensF...lld:pubmed
pubmed-article:3948153pubmed:authorpubmed-author:VitolsK SKSlld:pubmed
pubmed-article:3948153pubmed:authorpubmed-author:HendersonG...lld:pubmed
pubmed-article:3948153pubmed:authorpubmed-author:SureshM RMRlld:pubmed
pubmed-article:3948153pubmed:issnTypePrintlld:pubmed
pubmed-article:3948153pubmed:volume46lld:pubmed
pubmed-article:3948153pubmed:ownerNLMlld:pubmed
pubmed-article:3948153pubmed:authorsCompleteYlld:pubmed
pubmed-article:3948153pubmed:pagination1639-43lld:pubmed
pubmed-article:3948153pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:meshHeadingpubmed-meshheading:3948153-...lld:pubmed
pubmed-article:3948153pubmed:year1986lld:pubmed
pubmed-article:3948153pubmed:articleTitleTransport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.lld:pubmed
pubmed-article:3948153pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3948153pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3948153pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3948153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3948153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3948153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3948153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3948153lld:pubmed